This article is intended exclusively for licensed medical professionals. The content below is provided for educational purposes within the field of aesthetic medicine and must not be interpreted as promotional material for the general public.
Nouveau Visage is a French brand developed expressly for healthcare professionals in aesthetic medicine. Their product line focuses on Nouveau Visage Exosomes Therapy, a cutting-edge approach that combines exosomes, polynucleotides, and biomimetic peptides to support skin regeneration, collagen stimulation, and complementary care in aesthetic treatments.
The goal of this article is to present the complete range of Nouveau Visage products, highlight their technical innovations, and outline their intended clinical uses in practice — so that medical professionals and clinics can incorporate Nouveau Visage Exosomes Therapy effectively into their treatment protocols.
Innovations behind Nouveau Visage
Exosome Biomimetic Therapy
One of the signature innovations of Nouveau Visage is what they term “Exosomes Biomimetic Therapy”. According to their own site, they integrate over 100 billion exosomes into certain formulas to emulate and amplify the signaling mechanisms used by skin cells. Nouveau Visage
Exosomes are small extracellular vesicles (typically 30–150 nm) capable of carrying proteins, lipids, RNAs, and microRNAs, which can modulate recipient cell behavior. In regenerative medicine, exosomes are being investigated for their roles in cellular communication, repair, and anti-inflammatory signaling. PMC
Nouveau Visage also uses biomimetic peptides and polynucleotides to support skin physiology, aiming to mimic native skin repair pathways. Nouveau Visage
By designing combinations of these bioactive agents, they seek to deliver “regenerative serums” that do more than cosmetic superficial effect — targeting deeper skin resilience, repair, and quality.
Product Line Overview & Clinical Purposes
Based on the Nouveau Visage “Products” listing, their catalog is organized into five collections, each associated with a specific skin zone or function. Nouveau Visage
Below is a detailed breakdown:
| Collection / Product | Core Innovation(s) | Key Ingredients / Claims | Clinical Intended Use / Benefit |
|---|---|---|---|
| Collection 1: Newderm Age Control / Le Sérum Newage | Regeneration, anti-aging | Exosomes, peptides, polynucleotides | Broad anti-aging serum to support collagen, firmness, baseline rejuvenation |
| Collection 2: Newderm Bright / Newskin | Brightening, skin tone, barrier support | Exosomes + brightening peptides, folate derivatives | For pigmentation, tone correction, skin uniformity |
| Collection 3: Neweye / Eye Serums | Delicate eye zone regeneration | Exosomes + peptides tailored for periorbital skin | Reducing dark circles, fine lines, periocular quality |
| Collection 4: Newhair | Scalp / Hair microenvironment support | Exosomes, peptides directed to follicles | Adjunct to hair regeneration protocols (e.g. microneedling, PRP) |
| Collection 5: Newlift / Sérum Newlift | Lifting / firming support | Exosomes + peptides targeting dermal architecture | Support tightening, mild sagging zones, reinforce tissue tone |
Each serum is meant as a complementary tool, not as a standalone volumizer. They are best used adjunctively to in-clinic procedures like microneedling, energy-based devices, lasers, or injectables.
How Clinicians Can Use Nouveau Visage in Practice
Adjunct to Procedural Treatments
After microneedling, fractional laser, or radiofrequency, applying a regenerative serum that contains exosomes and peptides may:
- Accelerate healing
- Support collagenesis
- Reduce downtime
- Improve skin quality outcomes
By optimizing the post-procedure environment, these products may enhance patient satisfaction and prolong effects.
Preconditioning and Maintenance
Using these serums before treatments can precondition the skin (increase resilience, reduce reactive inflammation). Between sessions, they act as maintenance regimens to preserve gains in texture, firmness, hydration, and glow.
Zone-Specific Customization
Because Nouveau Visage offers zone-specific lines (eye, hair, lift), clinicians can tailor adjunctive care based on which area was treated. For example, after periocular energy-based therapy, one might use Neweye instead of a general serum.
Combination Strategy
These serums are designed to synergize with other modalities. However:
- Avoid overlapping aggressive actives immediately (e.g. intense peels) with these serums
- Sequence timing appropriately (serum application post-procedure or delayed by 24h, per clinic protocol)
- Monitor for compatibility if combining with potent topical actives (e.g. retinoids, strong acids)
Safety, Considerations, and Evidence
Safety Notes
- Exosome therapies are emerging technology. While promising, the regulatory scrutiny of exosome-based products is increasing. Some jurisdictions warn against unapproved marketing of exosomes. Wikipedia
- It’s essential that clinicians check the source, purity, sterility, and documentation of such products.
Mechanistic Evidence
A recent review summarizes the advances in exosomes for medical applications, including fabrication, administration, storage, and their roles in tissue repair. PMC
The review highlights how exosome therapy can influence inflammation, angiogenesis, extracellular matrix remodeling — all processes relevant to aesthetic dermatology.
Limitations
- There is less published clinical trial data specifically for many of these serums (brand-level) than for well-established injectables or lasers.
- The results are more gradual and supportive rather than dramatic structural changes.
- Patient expectations must be managed: these are complementary, not substitute, therapies.
Clinical Implementation Tips (for Physicians & Clinics)
- Protocol Design: Create standard protocols for pre-procedure, post-procedure, and maintenance phases incorporating Nouveau Visage serums.
- Patient Stratification: Use serums for patients with moderate aging or needing skin support rather than requiring major volume correction.
- Monitoring & Documentation: Use standardized photos, skin texture scoring, dermoscopy or devices for before/after metrics.
- Education & Consent: Inform patients about the regenerative nature, expected timeline (weeks to months), and that the products are adjunctive.
- Supplier Validation: Only procure through authorized distributors to ensure chain-of-custody, authenticity, and correct storage.
- Integration with other modalities: Promote synergy, not overlap. For instance, apply serum after a 24-hour recovery post-laser, not immediately.
Summary & Outlook
Nouveau Visage presents a comprehensive regenerative adjunctive platform for aesthetic professionals. Their innovation lies in combining exosomes, biomimetic peptides, and polynucleotides in zone-specific serums designed to support healing, collagen stimulation, and tissue quality enhancement.
While these are not volumizing agents, they shine as support tools in modern aesthetic protocols — before, after, and between treatments — to enhance outcomes, reduce recovery, and maintain skin health.
As exosome and regenerative aesthetic science evolves, clinics that adopt rigorous protocols, proper sourcing, and patient education can lead in offering next-generation adjunctive therapies.
Official & Brand Sources
- Nouveau Visage – Official Website
https://www.nouveau-visage.com/ - Nouveau Visage – Product Portfolio (Collections & Serums)
https://www.nouveau-visage.com/products/
Scientific & Educational References
- Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes.
Science. 2020;367(6478):eaau6977.
https://www.science.org/doi/10.1126/science.aau6977 - Pegtel DM, Gould SJ. Exosomes.
Annual Review of Biochemistry. 2019;88:487–514.
https://pubmed.ncbi.nlm.nih.gov/30388033/ - Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Current trends in therapeutic application of exosomes in cancer, immune diseases, and regenerative medicine.
International Journal of Nanomedicine. 2021;16:75–106.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7816837/ - Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential.
Cell & Bioscience. 2019;9(19).
https://pmc.ncbi.nlm.nih.gov/articles/PMC6397026/ - Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell–cell messengers in cardiovascular diseases.
Circulation Research. 2014;114(2):345–353.
https://pubmed.ncbi.nlm.nih.gov/24436430/ - U.S. Food and Drug Administration (FDA). Consumer Alert on Regenerative Medicine Products Including Exosome Products.
https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-exosome-products - European Medicines Agency (EMA). Medical Devices – Regulation and Oversight (CE-marked Aesthetic Products).
https://health.ec.europa.eu/medical-devices-sector_en - National Center for Biotechnology Information (NCBI) – Exosome Applications in Skin Regeneration.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9810265/
⚕️ This article is intended exclusively for licensed medical professionals. The information provided herein is for educational and scientific discussion within the field of aesthetic medicine.